These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6094415)

  • 21. Pradimicins M, N, O and P, new dihydrobenzo[a]naphthacenequinones produced by blocked mutants of Actinomadura hibisca P157-2.
    Sawada Y; Tsuno T; Yamamoto H; Nishio M; Konishi M; Oki T
    J Antibiot (Tokyo); 1990 Nov; 43(11):1367-74. PubMed ID: 2272913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of benazepril, an angiotensin-converting enzyme inhibitor, combined with CGS 35066, a selective endothelin-converting enzyme inhibitor, on arterial blood pressure in normotensive and spontaneously hypertensive rats.
    Battistini B; Ayach B; Molez S; Blouin A; Jeng AY
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():363S-366S. PubMed ID: 12193123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenacein--an angiotensin-converting enzyme inhibitor produced by a streptomycete. II. Isolation, structure determination and synthesis.
    Liu WC; Parker WL; Brandt SS; Atwal KS; Ruby EP
    J Antibiot (Tokyo); 1984 Nov; 37(11):1313-9. PubMed ID: 6096341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new class of angiotensin-converting enzyme inhibitors.
    Patchett AA; Harris E; Tristram EW; Wyvratt MJ; Wu MT; Taub D; Peterson ER; Ikeler TJ; ten Broeke J; Payne LG; Ondeyka DL; Thorsett ED; Greenlee WJ; Lohr NS; Hoffsommer RD; Joshua H; Ruyle WV; Rothrock JW; Aster SD; Maycock AL; Robinson FM; Hirschmann R; Sweet CS; Ulm EH; Gross DM; Vassil TC; Stone CA
    Nature; 1980 Nov; 288(5788):280-3. PubMed ID: 6253826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Derivatives of the potent angiotensin converting enzyme inhibitor 5(S)-benzamido-4-oxo-6-phenylhexanoyl-L-proline: effect of changes at positions 2 and 5 of the hexanoic acid portion.
    Almquist RG; Crase J; Jennings-White C; Meyer RF; Hoefle ML; Smith RD; Essenburg AD; Kaplan HR
    J Med Chem; 1982 Nov; 25(11):1292-9. PubMed ID: 6292422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin-converting enzyme inhibitors: synthesis and structure-activity relationships of potent N-benzyloxycarbonyl tripeptide inhibitors.
    Sawayama T; Tsukamoto M; Sasagawa T; Nishimura K; Yamamoto R; Deguchi T; Takeyama K; Hosoki K
    Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2417-22. PubMed ID: 2605684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation, identification and molecular docking studies of a new isolated compound, from Onopordon acanthium: a novel angiotensin converting enzyme (ACE) inhibitor.
    Sharifi N; Souri E; Ziai SA; Amin G; Amini M; Amanlou M
    J Ethnopharmacol; 2013 Jul; 148(3):934-9. PubMed ID: 23743058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antihypertensive effect of the new oral angiotensin converting enzyme inhibitor "MK-421".
    Gavras H; Biollaz J; Waeber B; Brunner HR; Gavras I; Davies RO
    Lancet; 1981 Sep; 2(8246):543-7. PubMed ID: 6116000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin converting enzyme inhibitors: N-substituted D-glutamic acid gamma dipeptides.
    Ksander GM; Yuan AM; Diefenbacher CG; Stanton JL
    J Med Chem; 1985 Nov; 28(11):1606-11. PubMed ID: 2999395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological activity of carboxylic acid replacement analogues of the potent angiotensin converting enzyme inhibitor 5(S)-benzamido-4-oxo-6-phenylhexanoyl-L-proline.
    Almquist RG; Chao WR; Jennings-White C
    J Med Chem; 1985 Aug; 28(8):1067-71. PubMed ID: 2991518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purification and characterization of an antihypertensive peptide from a yogurt-like product fermented by Lactobacillus helveticus CPN4.
    Yamamoto N; Maeno M; Takano T
    J Dairy Sci; 1999 Jul; 82(7):1388-93. PubMed ID: 10416158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological activity of a ketomethylene analogue of a tripeptide inhibitor of angiotensin converting enzyme.
    Almquist RG; Chao WR; Ellis ME; Johnson HL
    J Med Chem; 1980 Dec; 23(12):1392-8. PubMed ID: 6256550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery, purification and characterization of the angiotensin converting enzyme inhibitor, L-681,176, produced by Streptomyces sp. MA 5143a.
    Huang L; Rowin G; Dunn J; Sykes R; Dobna R; Mayles BA; Gross DM; Burg RW
    J Antibiot (Tokyo); 1984 May; 37(5):462-5. PubMed ID: 6203886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects.
    Brunner DB; Desponds G; Biollaz J; Keller I; Ferber F; Gavras H; Brunner HR; Schelling JL
    Br J Clin Pharmacol; 1981 May; 11(5):461-7. PubMed ID: 6268131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Total serum angiotensin converting enzyme activity in rats and dogs after enalapril maleate (MK-421).
    Ulm EH; Vassil TC
    Life Sci; 1982 Apr; 30(14):1225-30. PubMed ID: 6283285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. General pharmacology of the non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
    Shirota M; Hayashi M; Kajiwara Y; Kitabatake K; Uruno T; Kubota K
    Arzneimittelforschung; 1993 Nov; 43(11):1169-74. PubMed ID: 8292059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A metabolite of aspartame inhibits angiotensin converting enzyme.
    Grobelny D; Galardy RE
    Biochem Biophys Res Commun; 1985 Apr; 128(2):960-4. PubMed ID: 2986632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological activity of modified peptide inhibitors of angiotensin-converting enzyme.
    Roark WH; Tinney FJ; Cohen D; Essenburg AD; Kaplan HR
    J Med Chem; 1985 Sep; 28(9):1291-5. PubMed ID: 2993618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ketomethyldipeptides I. A new class of angiotensin converting enzyme inhibitors.
    Natarajan S; Gordon EM; Sabo EF; Godfrey JD; Weller HN; Pluscec J; Rom MB; Cushman DW
    Biochem Biophys Res Commun; 1984 Oct; 124(1):141-7. PubMed ID: 6093782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antihypertensive effects of CI-907 (indolapril): a novel nonsulfhydryl angiotensin converting enzyme inhibitor.
    Ryan MJ; Boucher DM; Cohen DM; Essenburg AD; Major TC; Mertz TE; Olszewski BJ; Randolph AE; Singer RM; Kaplan HR
    J Pharmacol Exp Ther; 1984 Feb; 228(2):312-8. PubMed ID: 6319675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.